Semaglutide is administered as a once-weekly subcutaneous injection (marketed as Ozempic for diabetes and Wegovy for weight management) or as a daily oral tablet (Rybelsus)
As expected based on its ability to sharply reduce the body weight and normalize the glucose levels, semaglutide lowered the risk of heart attacks, strokes and cardiovascular deaths by as much as 20%
Use caution with insulin/sulfonylureas (hypoglycemia), a history of gallbladder disease, diabetic retinopathy, or significant kidney disease
Taking 20 years of research, Hilos lightweight wristband passively captures blood pressure readings throughout the day and night, delivering up to 800 measurements per monthall without disrupting the users daily life
It shares 94 percent amino acid homology with native human GLP-1, but includes structural modifications that extend its half-life to roughly seven days